OTC · Drug Manufacturers - Specialty & Generic

Grown Rogue International Inc. (GRUSF) Stock

$0.41 +2.68% OTC: GRUSF Healthcare

Grown Rogue International Inc., operating through its subsidiary entities, focuses on the cultivation and retail of cannabis products across the United States. Its diverse product portfolio includes a variety of cannabis flower, such as indica, sativa, and hybrid strains, alongside edibles, vaporization cartridges, pre-rolled joints, and concentrated cannabis forms.

Valuation

MetricValue
Price$0.41
Market Cap$102.47M
P/E Ratio-123.21
P/B Ratio6.03
P/S Ratio2.83
EPS (TTM)$0.03
52-Week High$0.52
52-Week Low$0.27
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE1.34%
ROA0.49%
ROCE-5.30%
Gross Margin43.77%
Operating Margin-8.52%
Net Margin0.90%
Debt/Equity1.63
Current Ratio2.99

Annual Financials (USD)

Metric20212022202320242025
Revenue$9.0M$18.0M$22.0M$27.0M$32.0M
Operating Profit$1.0M$1.0M$3.0M$1.0M$2.0M
Net Profit$-2.0M$0$-1.0M$-11.0M$2.0M
EPS$-0.02$0.00$0.00$-0.05$0.03
Op Margin7.5%5.4%11.7%4.2%6.2%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$14.0M$16.0M$30.0M$43.0M$56.0M
Total Liabilities$7.0M$7.0M$18.0M$27.0M$24.0M
Cash$1.0M$2.0M$9.0M$5.0M$13.0M
Borrowings$5.0M$5.0M$7.0M$8.0M$17.0M

Latest News

Grown Rogue to Report Second Quarter 2026 Financial Results and Host Conference Call; Announces Equity Incentive Grants CNW Group · Jul 27, 2026 Grown Rogue Partner SEA Craft Restarts Cultivation at Dwight, Illinois Facility CNW Group · Jun 16, 2026 TSX Penny Stocks To Watch In May 2026 Simply Wall St. · May 20, 2026 Grown Rogue International Inc (GRUSF) Q1 2026 Earnings Call Highlights: Strategic Expansions ... GuruFocus.com · May 13, 2026 Grown Rogue Reports First Quarter 2026 Results CNW Group · May 12, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$0$2.0M$6.0M$2.0M$2.0M
Investing Cash Flow$-5.0M$-2.0M$-4.0M$-10.0M$-6.0M
Financing Cash Flow$0$0$0$2.0M$-1.0M
Net Cash Flow$1.0M$0$7.0M$-4.0M$7.0M
Free Cash Flow$-2.0M$1.0M$4.0M$5.0M$1.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.75
EV / EBITDA36.01
FCF Yield-0.05%
Quick Ratio2.13
Interest Coverage-1.94
Return 1Y7.89%
Return 3Y115.79%
Return 5Y—

Ownership

Insiders Held29.60%
Institutions Held8.61%
Institutions Float Held12.23%
Institutional HolderSharesReport Date
Beaumont Financial Advisors, LLC200,0002024-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
BIOYFBioSyent Inc. $10.50 +0.41% 18.10 $120.04M 1.52%
ETSTEarth Science Tech, Inc. $0.15 +7.14% 12.20 $43.23M 0.00%
GGBXFGreen Growth Brands Inc. $0.00 — 0.00 $2061 0.00%
HSCHFH-Source Holdings Ltd. $0.00 — 0.00 $1176 0.00%
IUGNFImugene Limited $0.10 +0.00% -0.40 $41.60M 0.00%

About Grown Rogue International Inc.

Grown Rogue International Inc., operating through its subsidiary entities, focuses on the cultivation and retail of cannabis products across the United States. Its diverse product portfolio includes a variety of cannabis flower, such as indica, sativa, and hybrid strains, alongside edibles, vaporization cartridges, pre-rolled joints, and concentrated cannabis forms. The company's merchandise is distributed and sold primarily through licensed dispensaries. Grown Rogue International Inc.'s corporate headquarters are located in Medford, Oregon.

Grown Rogue International Inc. is headquartered in US.

Grown Rogue International Inc. (GRUSF) stock trades at $0.41 with a market capitalization of $102.47M. The stock is valued at a price-to-earnings (P/E) ratio of -123.21, price-to-book of 6.03, price-to-sales of 2.83. Over the past 52 weeks the stock has ranged between $0.27 and $0.52, and currently trades 21.2% below its 52-week high.

On profitability, Grown Rogue International Inc. generates a return on equity (ROE) of 1.34%, return on capital employed of -5.30%, an operating margin of -8.52%, a net profit margin of 0.90%.

Official website: www.grownrogue.com

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides